Trade Galapagos NV - GLPG CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.017257% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.004965% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Netherlands | ||||||||
| Commission on trade | 0% |
| Prev. Close | 22.45 |
| Open | 22.25 |
| 1-Year Change | -18.94% |
| Day's Range | 22.25 - 23.15 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 24, 2025 | 22.90 | 0.45 | 2.00% | 22.45 | 23.15 | 22.10 |
| Apr 23, 2025 | 22.45 | 0.25 | 1.13% | 22.20 | 22.50 | 22.05 |
| Apr 22, 2025 | 21.90 | 0.05 | 0.23% | 21.85 | 22.00 | 21.35 |
| Apr 17, 2025 | 21.80 | 0.25 | 1.16% | 21.55 | 21.95 | 21.30 |
| Apr 16, 2025 | 21.65 | 0.70 | 3.34% | 20.95 | 21.75 | 20.85 |
| Apr 15, 2025 | 21.10 | -0.25 | -1.17% | 21.35 | 21.40 | 20.60 |
| Apr 14, 2025 | 21.15 | -0.15 | -0.70% | 21.30 | 21.75 | 21.05 |
| Apr 11, 2025 | 21.15 | -0.10 | -0.47% | 21.25 | 21.40 | 20.75 |
| Apr 10, 2025 | 21.10 | -1.25 | -5.59% | 22.35 | 22.45 | 21.05 |
| Apr 9, 2025 | 21.15 | 0.50 | 2.42% | 20.65 | 21.35 | 20.65 |
| Apr 8, 2025 | 22.05 | 0.90 | 4.26% | 21.15 | 22.60 | 21.05 |
| Apr 7, 2025 | 20.85 | 0.30 | 1.46% | 20.55 | 21.70 | 19.85 |
| Apr 4, 2025 | 21.60 | 0.00 | 0.00% | 21.60 | 21.95 | 21.30 |
| Apr 3, 2025 | 21.85 | 0.10 | 0.46% | 21.75 | 22.70 | 21.75 |
| Apr 2, 2025 | 23.05 | 0.30 | 1.32% | 22.75 | 23.05 | 22.45 |
| Apr 1, 2025 | 23.25 | 0.50 | 2.20% | 22.75 | 23.55 | 22.75 |
| Mar 31, 2025 | 23.15 | -0.05 | -0.22% | 23.20 | 23.20 | 22.65 |
| Mar 28, 2025 | 23.45 | 0.00 | 0.00% | 23.45 | 23.70 | 23.35 |
| Mar 27, 2025 | 23.55 | 0.25 | 1.07% | 23.30 | 23.65 | 23.30 |
| Mar 26, 2025 | 23.65 | -0.20 | -0.84% | 23.85 | 23.85 | 23.55 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Galapagos NV Company profile
About Galapagos NV
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Galapagos NV revenues increased 2% to EUR538.6M. Net loss before extraordinary items decreased 60% to EUR125.4M. Revenues reflect Total net revenues increase of 1% to EUR484.8M, Other operating income increase of 3% to EUR53.7M. Basic Earnings per Share excluding Extraordinary Items increased from -EUR4.78 to -EUR1.92.
Equity composition
23754226 shares @12/31/04 1 for 4 split = shares 5938556 ipo may 2005 = shares 9170167 @ 06/30/05 H1 figures
| Industry: | Biotechnology & Medical Research (NEC) |
Generaal De Wittelaan L11 A3
MALINES (MECHELEN)
ANTWERPEN 2800
BE
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com